Royalty Pharma Ownership | Who Owns Royalty Pharma?


OverviewForecastRevenueFinancialsChartTranscripts

Royalty Pharma Ownership Summary


Royalty Pharma is owned by 46.45% institutional investors, 7.17% insiders, and 46.38% retail investors. Morgan stanley is the largest institutional shareholder, holding 10.09% of RPRX shares. American Funds New Perspective A is the top mutual fund, with 4.58% of its assets in Royalty Pharma shares.

RPRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRoyalty Pharma46.45%7.17%46.38%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley43.57M10.09%$2.09B
Capital investors35.01M8.11%$1.68B
Blackrock funding, inc. /de25.91M6.00%$1.24B
Fmr25.15M5.82%$1.21B
Blackrock23.02M5.13%$606.97M
Baillie gifford16.16M3.74%$774.99M
Swedbank ab11.59M2.68%$555.81M
State street10.99M2.54%$527.18M
Vanguard group9.93M2.30%$383.87M
Capital world investors8.04M1.86%$385.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caledonia (private) investments pty7.17M10.00%$343.87M
Dorsey asset management2.28M8.70%$109.21M
Regal partners2.62M6.84%$125.90M
Davern capital partners, lp520.01K6.84%$24.94M
Patient capital management3.64M6.39%$174.79M
Lion point capital, lp21.40K6.14%$1.03M
New south capital management2.63M6.04%$125.96M
Cm management125.00K5.01%$6.00M
Cutter capital management, lp356.89K4.84%$11.11M
Torray investment partners645.42K4.54%$30.96M

Top Buyers

HolderShares% AssetsChange
Capital world investors8.04M0.05%8.04M
Capital investors35.01M0.39%3.90M
Royal london asset management3.81M0.38%3.63M
Norges bank3.41M0.01%3.41M
Invesco3.75M0.03%2.25M

Top Sellers

HolderShares% AssetsChange
Morgan stanley43.57M0.13%-11.70M
Unisphere establishment---5.00M
Adage capital partners gp7.48M0.55%-4.26M
Viking global investors lp---2.60M
Citadel advisors2.68M0.02%-2.59M

New Positions

HolderShares% AssetsChangeValue
Capital world investors8.04M0.05%8.04M$385.52M
Norges bank3.41M0.01%3.41M$131.92M
Vanguard fiduciary trust2.04M0.03%2.04M$97.99M
Vanguard asset management806.14K0.03%806.14K$38.67M
Renaissance790.94K0.06%790.94K$37.94M

Sold Out

HolderChange
Wealth watch advisors-1.00
Financial gravity asset management-2.00
Harbor investment advisory-4.00
Optima capital-5.00
Palisade asset management-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026454-16.08%200,591,255-43.79%460.67%256-24.26%137-
Dec 31, 2025409-17.71%269,689,122-17.74%621.09%253-14.53%102-24.44%
Sep 30, 20254823.43%326,746,376-4.38%751.16%28715.26%130-16.13%
Jun 30, 2025456-1.30%341,289,0057.83%801.51%248-1482.07%
Mar 31, 20253-99.28%2,405,220-99.25%-0.01%1-99.58%2-98.51%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds New Perspective A19.65M4.58%9.56M
Capital Group New Perspective Comp19.65M4.58%9.56M
Vanguard US Total Market Shares ETF12.01M2.77%-167.60K
Vanguard Total Stock Mkt Idx Inv11.25M2.60%-258.49K
American Funds Capital Income Bldr A8.58M2.00%6.87M
American Funds American Balanced A8.02M1.87%-
Vanguard Mid Cap Index Institutional7.99M1.85%86.30K
American Funds Growth Fund of Amer A6.41M1.50%2.03M
Capital Group Growth Fnd of Amer Comp6.41M1.50%2.03M
Morgan Stanley Inst Growth I5.50M1.28%-440.57K

Recent Insider Transactions


DateNameRoleActivityValue
May 14, 2026Urist Marshall EVP, Research & InvestmentsSell$726.14K
May 14, 2026Norden Gregory-Sell$161.38K
Apr 28, 2026Coyne Terrance P. EVP & CFOSell$1.64M
Apr 28, 2026Coyne Terrance P. EVP & CFOSell$93.33K
Apr 01, 2026Coyne Terrance P. EVP & CFOSell$90.62K

Insider Transactions Trends


DateBuySell
2026 Q2-6
2026 Q1-23
2025 Q4-28
2025 Q3-1
2025 Q2--

RPRX Ownership FAQ


Who Owns Royalty Pharma?

Royalty Pharma shareholders are primarily institutional investors at 46.45%, followed by 7.17% insiders and 46.38% retail investors. The average institutional ownership in Royalty Pharma's industry, Biotech Stocks , is 34.83%, which Royalty Pharma exceeds.

Who owns the most shares of Royalty Pharma?

Royalty Pharma’s largest shareholders are Morgan stanley (43.57M shares, 10.09%), Capital investors (35.01M shares, 8.11%), and Blackrock funding, inc. /de (25.91M shares, 6.00%). Together, they hold 24.19% of Royalty Pharma’s total shares outstanding.

Does Blackrock own Royalty Pharma?

Yes, BlackRock owns 5.13% of Royalty Pharma, totaling 23.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 606.97M$. In the last quarter, BlackRock increased its holdings by 1.81M shares, a 8.54% change.

Who is Royalty Pharma’s biggest shareholder by percentage of total assets invested?

Caledonia (private) investments pty is Royalty Pharma’s biggest shareholder by percentage of total assets invested, with 10.00% of its assets in 7.17M Royalty Pharma shares, valued at 343.87M$.

Who is the top mutual fund holder of Royalty Pharma shares?

American Funds New Perspective A is the top mutual fund holder of Royalty Pharma shares, with 4.58% of its total shares outstanding invested in 19.65M Royalty Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools